Living with inflammatory bowel disease (IBD) can be extremely frustrating to people with the condition, significantly affecting their quality of life. Moreover, the 1.6 million Americans that live with IBD often feel misunderstood by friends and family members who often minimize their condition, as well as offer medical guidance based on their preconceived notions.
IBD is a term used for two conditions that are known to cause chronic inflammation of the gastrointestinal (GI) tract – Crohn’s disease and ulcerative colitis. The exact cause of IBD is unknown. Possible causes include the immune system responding incorrectly to certain environmental factors which can result in inflammation. People with family histories of IBD are more likely to develop it, but no direct genetic link has been found.
Together, We Know IBD is a campaign from Janssen designed to break through the misconceptions surrounding IBD, as well as motivate people living with the condition and Health Care Providers (HCPs) to talk about their condition, continued research in the field.
In this interview, Dr. Satish Iduru from GI Specialists of Houston discusses:
· The importance of advancing the science of IBD treatment so that one day, long- lasting remission can be a possibility for more people living with IBD
· The importance of all communities having a voice in clinical research to ensure that diverse populations of people impacted by the disease are represented in clinical research
· Janssen’s commitment to better serving IBD patients in underrepresented communities
· The importance of advancing the science of IBD treatment so that one day, long- lasting remission can be a possibility for more people living with IBD
· The importance of all communities having a voice in clinical research to ensure that diverse populations of people impacted by the disease are represented in clinical research
· Janssen’s commitment to better serving IBD patients in underrepresented communities
Interview is courtesy: Janssen
No comments:
Post a Comment